The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple negative breast cancer.

Vangangelt KMH, Green AR, Heemskerk IMF, Cohen D, van Pelt GW, Sobral-Leite M, Schmidt MK, Putter H, Rakha EA, Tollenaar RAEM, et al. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple negative breast cancer. Int J Cancer. 2020.